Events

 

2pm, India Time

January 13 2022

Online Webinar

 

Program & Speakers

 

Topic : Early detection & management of CKD- a Nephrologist’s perspective

Dr Ganesh Prasad, Sr Nephrologist, Fortis Hospital, Chennai

 

 

 

Topic : CKD reporting from clinical chemistry lab – an update

Dr Barnali Das, Clinical Biochemist, Kokilaben Dhirubhai Ambani Hospital, Mumbai

 

Topic : Haematological manifestations in CKD

Dr Shanaz Khodaiji, Consultant Haematologist-Hinduja Hospital, Mumbai

 

 

Topic : Haematuria- Urine flow cytometry to the rescue

Dr CN Srinivas, Vice-president –Technical operations, Head HLA and TI laboratory, SRL Diagnostics, Head-Department of Laboratory Medicine Fortis Hospitals, Vadapalani, Chennai

In Asia, the incidence of kidney disease of all types is growing more rapidly than developed western countries in part due to increasing rates of diabetes and hypertension. Across the continent, the population of end-stage renal disease patients requiring dialysis is growing at an annual rate of more than 12%. This rapid growth is proving costly. Most kidney diseases are untreated or undetected in its earliest stages and is expensive to manage as it progresses to end stage renal failure. There are a host of technological advances in renal disease treatment and management but what many clinicians and health governments hope for now is early detection. Recognition of a kidney dysfunction in the earliest stages will have the largest impact to reducing social and economic burdens. To stay updated & informed, we invite you to the Minds Together – Sysmex Knowledge Congregation titled “RBC DAY”, where we have stalwarts in the industry, educate & discuss with us on relevant laboratory support in early detection & monitoring of kidney disease.

X

You are redirected to a 3rd party website!

Clicking on a social media link implies that you understand you are leaving our site and entering a third-party website. We are not responsible for their content, privacy policies, or terms of use. Please review their terms and privacy policy before proceeding. We do not endorse or control the third-party website and disclaim any liability for damages or consequences.